Edge­wise boosts aware­ness of rare Beck­er mus­cu­lar dy­s­tro­phy as it pur­sues po­ten­tial first ther­a­py

As Edge­wise Ther­a­peu­tics works to­wards its first FDA drug ap­proval, the small bio­phar­ma is al­ready launch­ing re­sources for one of the rare dis­ease com­mu­ni­ties it …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER